MedPath

DIPENTUM

DIPENTUM

Approved
DIN Number

02063808

Drug Class

Human

Market Date

Dec 31, 1995

Company
HC

searchlight pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02063808
AIG Number0122225002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
A07EC03 OLSALAZINE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:36.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

OLSALAZINE SODIUMActive
Strength: 250 MG
Monograph: OLSALAZINE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.